Products

ADAS 3D
ADAS 3D
Cardiology AI
ADAS 3D is an AI-powered medical software for electrophysiologists, designed to extract key information from cardiac MRI & CT images for advanced fibrosis analysis and comprehensive EP procedure planning and guidance.

See all 1 product →

About ADAS 3D

ADAS 3D (Adas3D Medical S.L.) is a healthcare AI company that develops advanced image processing software for cardiac electrophysiologists. Their core product is a standalone software tool that processes cardiovascular enhanced Magnetic Resonance (MR) images and Computed Tomography Angiography (CTA) images in DICOM format. The software utilizes machine learning to automatically identify and segment cardiac structures, including the left ventricle, left atrium, coronary arteries, and other anatomical features.

For physicians, ADAS 3D provides crucial information for understanding cardiovascular disease, particularly myocardial scarring caused by ischemic or non-ischemic heart disease. It enables the visualization of fibrosis, wall thickness, and surrounding anatomical structures in 3D models of the heart. This detailed analysis supports clinical decision-making, pre-planning, and guidance during electrophysiology procedures such as atrial fibrillation and ventricular tachycardia ablations. The software can export 3D models and data to industry-standard file formats, facilitating integration with catheter navigation systems to serve as a roadmap during interventions.

Focus Areas

cardiac imaging electrophysiology arrhythmia treatment fibrosis analysis 3D modeling MRI post-processing CT angiography post-processing AI in medical imaging

Business Intelligence

TechnologySoftware-based image processing tool, AI-powered automated segmentation (coming soon)

What Physicians Need to Know

Cardiac Imaging & 3D Modeling
ADAS 3D specializes in post-processing cardiovascular Magnetic Resonance (MRI) and Computed Tomography Angiography (CTA) images to create detailed 3D models of the heart. This includes visualizing the left ventricle (LV) and left atrium (LA), identifying fibrosis, and mapping surrounding anatomical structures like the aorta and esophagus. Their software helps in understanding the fibrotic substrate and myocardial wall thickness.
Electrophysiology & Arrhythmia Treatment
The company's core mission is to enhance electrophysiology procedures by integrating advanced cardiac imaging. ADAS 3D software aids electrophysiologists in identifying arrhythmia substrates, planning treatment approaches, and guiding catheter ablation procedures. It helps in visualizing areas with defective electrical signals and determining optimal ablation targets.
Fibrosis Analysis
A key specialization is the quantification and visualization of fibrosis in the myocardium from MRI images. The software automatically identifies fibrotic areas and can display the left ventricle in concentric layers to assess scar transmurality and detect anatomical corridors.
MRI & CT Angiography Post-processing
ADAS 3D's software is a post-processing tool for DICOM-formatted cardiovascular MRI and CTA images. It extracts crucial clinical information for diagnostic decision-making, planning, and guidance of EP procedures. The software can automatically segment cardiac structures, including the left ventricle, left atrium, and coronary arteries.
AI in Medical Imaging
ADAS 3D utilizes AI and machine learning for automated segmentation of specific image sequences, which helps in identifying and segmenting cardiac structures. This technology aims to improve the efficiency and practicality of image post-processing in daily electrophysiology routines.
Physician Tip

For physicians, ADAS 3D offers a comprehensive tool for pre-procedural planning, intra-procedural guidance, and post-procedural review in electrophysiology. The ability to visualize and quantify fibrosis, understand myocardial wall thickness, and create detailed 3D heart models from MRI and CT images can significantly enhance decision-making for arrhythmia treatment, particularly for complex cases like atrial fibrillation and ventricular tachycardia. The export functionality to EP navigation systems allows for seamless integration into existing workflows, providing a roadmap for catheter navigation and potentially leading to more effective, rapid, and safer procedures. The software's ability to automatically detect border-zone corridors and provide tissue characterization in layers can increase operator confidence and improve patient outcomes. While ADAS 3D requires on-site processing and user expertise, it delivers nuanced results and detailed visualization of conduction corridors, which can be valuable for targeted ablation planning.

ADAS 3D software is available in the Siemens Healthineers' Digital Marketplace and integrates with syngo.via OpenApps, allowing cardiologists and electrophysiologists to use it in clinical settings for cardiac MR and CTA image analysis. It is also accessible through cvi42 for planning left atrial and left ventricular procedures. The 3D models generated by ADAS 3D can be exported for visualization to electrophysiology (EP) navigation systems, facilitating integration with existing lab equipment. Furthermore, ADAS 3D has partnered with Stereotaxis to combine advanced preoperative substrate mapping with robotic magnetic navigation technologies, aiming for more reproducible treatment during cardiac ablation. The software is designed to process DICOM images, ensuring compatibility with standard medical imaging formats.

Products by ADAS 3D

1 product in the directory

ADAS 3D
ADAS 3D
Cardiology AI
ADAS 3D is an AI-powered medical software for electrophysiologists, designed to extract key information from cardiac MRI & CT images for advanced fibrosis analysis and comprehensive EP procedure planning and guidance.

What the Web Says

ADAS 3D, developed by Adas3D Medical S.L., is a medical software that creates 3D models from MRIs, CT scans, and other imaging techniques to assist in the diagnosis, planning, and execution of surgical interventions, particularly for arrhythmia. The product was initially launched in 2017 and received FDA clearance in June 2026. While there is information available about the product's technical specifications and scientific backing, comprehensive user reviews from platforms like G2, Glassdoor, Capterra, and Reddit specifically for "ADAS 3D" (adas3d.com) are limited or difficult to distinguish from other companies or products using "ADAS" or "3D" in their names.

Overall: Mixed

Strengths

  • Assists in diagnosis, planning, and execution of surgical interventions, especially for arrhythmia.
  • Creates interactive 3D views of LA-MRI, LA-CTA, LV 2D DE-MRI, LV 3D DE-MRI, and LV-CTA for tissue characterization.
  • Connects with PACS for DICOM retrieval and centralized case storage.
  • Offers floating licenses for access from multiple computers within a hospital.
  • Provides training tutorials, user manuals, and technical support.
  • Backed by scientific evidence and publications.

Limitations

  • Limited readily available product reviews from target platforms (G2, Glassdoor, Capterra, Reddit).
  • Difficulty in distinguishing reviews for "ADAS 3D" from other ADAS or 3D-related companies/products.
  • No specific employer reviews found for Adas3D Medical S.L. on the requested platforms.

Based on reviews from: Google Search, FDA, Fundació Bosch i Gimpera, adas3d.com

Last updated: 2026-10-21

Videos

News, demos, and interviews about ADAS 3D.

Loading videos...

Videos load interactively. If none appear, search YouTube for ADAS 3D →

View all on YouTube

Press & Coverage

Adas 3D
Update on U.S. Reimbursement and Coding for 3D Predictive Cardiac Modeling (HCPCS Code C9793)
ADAS3D Medical announced an update on U.S. reimbursement and coding for 3D predictive cardiac modeling (HCPCS Code C9793). This indicates ongoing efforts to integrate their technology into standard clinical practice and secure appropriate financial pathways.
2025-10
Journal of Innovation in Cardiac Rhythm Management
ADAS 3D software is now available in the Siemens Healthineers' Digital Marketplace
Adas3D Medical and Siemens Healthineers have partnered to make ADAS 3D software available on the Siemens Healthineers' Digital Marketplace, expanding its reach to hospitals globally. This integration allows cardiologists and electrophysiologists to utilize ADAS 3D within syngo.via OpenApps for enhanced cardiac imaging.
2026-01
Adas 3D
ADAS3D Medical Secures Chinese NMPA Approval for Software Distribution
ADAS3D Medical received approval from the Chinese National Medical Products Administration (NMPA) to distribute its advanced software throughout China. This approval is a significant milestone for the company's international growth strategy, enabling widespread deployment of its cardiac imaging solution in the Chinese market.
2024-06
Adas 3D
Breaking Boundaries in Healthcare: ADAS3D Highlights Latest Technologies at EHRA 2024
ADAS3D participated in the EHRA 2024 Congress, showcasing its visualization and analysis technology for cardiovascular health in over 20 scientific sessions. The company demonstrated its software's ability to accurately extract crucial anatomical structures and identify fibrosis, which was well-received by electrophysiology specialists.
2024-04
PubMed
Non-invasive detection of slow conduction with cardiac magnetic resonance imaging for ventricular tachycardia ablation - PubMed
This peer-reviewed article discusses the use of non-invasive myocardial scar characterization with cardiac magnetic resonance (CMR) to identify conduction channels, aiding ventricular tachycardia (VT) ablation. ADAS 3D Medical S.L. is listed as a contributor to this research.
2024-02
PMC
Comparative analysis of CT and CMR-derived ventricular models using ADAS 3D and inHEART for VT substrate assessment - PMC
This study compares CCT- and CMR-derived ventricular substrate models in VT patients using ADAS 3D and inHEART platforms to assess inter-platform differences. The research aims to enhance procedural guidance for catheter ablation procedures through advanced post-processing software.
2025-05
FDA AI Device Index
ADAS 3D by Adas3D Medical S.L. · FDA AI device (K253969)
ADAS 3D, developed by Adas3D Medical S.L., received FDA clearance through the 510(k) pathway on June 29, 2026, categorized as Automated Radiological Image Processing Software (Class II). This confirms its authorization for use as an AI-enabled medical device in the US.
2026-06
Oxford Academic
Quantification of left atrial fibrosis by 3D late gadolinium-enhanced cardiac magnetic resonance imaging in patients with atrial fibrillation: impact of different analysis methods - Oxford Academic
This article discusses the quantification of left atrial fibrotic burden using 3D late gadolinium-enhanced cardiac magnetic resonance imaging in atrial fibrillation patients, comparing open-source CEMRG software and commercially available ADAS 3D-LA software. The study investigates the impact of different analysis methods on fibrosis assessment.
2021-11

Frequently Asked Questions

ADAS 3D provides advanced 3D modeling and post-processing solutions for cardiac MRI and CT angiography, which are crucial for detailed anatomical understanding in electrophysiology. Our tools assist in visualizing cardiac structures, identifying arrhythmogenic substrates, and planning arrhythmia treatments by offering precise fibrosis analysis and 3D reconstructions of the heart.
Our technology enhances arrhythmia treatment by providing highly detailed 3D models of the heart, enabling better localization of targets for ablation procedures. Through sophisticated MRI post-processing, ADAS 3D offers quantitative fibrosis analysis, which is vital for risk stratification and guiding treatment strategies in patients with various cardiomyopathies.
ADAS 3D offers a suite of products focused on cardiac MRI and CT angiography post-processing, including modules for 3D modeling and fibrosis analysis. While specific product names and integration details would require a direct consultation, our solutions are designed to be compatible with standard DICOM inputs and can be integrated into existing PACS and hospital IT infrastructures.
ADAS 3D is committed to regulatory compliance to ensure the safety and efficacy of our AI-powered medical imaging products. While specific certifications like FDA clearance or CE marking would need to be verified through official documentation, we adhere to relevant medical device regulations for software as a medical device.
ADAS 3D prioritizes data security and patient privacy by implementing robust encryption and anonymization protocols in line with HIPAA and GDPR guidelines. Our AI algorithms are developed with ethical considerations, focusing on transparency, fairness, and clinical validation to ensure responsible and beneficial use in medical imaging.
The pricing structure for ADAS 3D's solutions typically varies based on the specific modules, licensing model, and scale of deployment. We offer comprehensive technical support, including dedicated customer service, regular software updates, and training programs to ensure healthcare professionals can effectively utilize our products.
ADAS 3D actively seeks partnerships with leading medical institutions and technology providers to advance our cardiac imaging and electrophysiology solutions. While specific partnership details are often confidential, the company is focused on continuous innovation and growth in the medical imaging AI sector, indicating a stable and forward-looking trajectory.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.